# Processa Pharmaceuticals, Inc.: Form 10-K/A for the period ended Dec 31, 2025

- Company: [Processa Pharmaceuticals, Inc.](/companies/pcsa.md) (CIK 1533743)
- Form: 10-K/A
- Filed: 2026-04-30
- Accepted by EDGAR: Apr 30, 2026, 17:14 ET
- Period: 2025-12-31
- Accession: 0001493152-26-020731
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1533743/000149315226020731/form10-ka.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1533743/000149315226020731/

## Sections

No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1533743/000149315226020731/form10-ka.htm

Filed Apr 30, 2026.
Source: SEC EDGAR, the filing index for accession 0001493152-26-020731. Last ingested by Listed: Nov 5, 2026, 12:19 ET. No prices; not investment advice.